Lansdale, PA, United States of America

Charles J McIntyre


Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 110(Granted Patents)


Location History:

  • Lansdale, NJ (US) (2010)
  • Lansdale, PA (US) (2003 - 2013)
  • Landsdale, PA (US) (2013)

Company Filing History:


Years Active: 2003-2013

Loading Chart...
15 patents (USPTO):

Title: The Innovative Journey of Charles J. McIntyre

Introduction: Charles J. McIntyre, a prominent inventor based in Lansdale, PA, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 15 patents, his work primarily focuses on developing therapeutic compounds that play a crucial role in combating viral infections, particularly hepatitis C. His innovative spirit has led to the creation of compounds that are instrumental in the fight against this challenging disease.

Latest Patents: One of McIntyre's noteworthy patents involves the development of therapeutic compounds characterized as macrocyclic compounds of a specific formula. These compounds serve as inhibitors of viral proteases, especially targeting the hepatitis C virus (HCV) NS3 protease. The patent outlines both the synthesis processes and the potential applications of these macrocyclic compounds in treating or preventing HCV infections. His dedication to innovation is further highlighted by another patent focused on HCV NS3 protease inhibitors, reiterating the importance of these compounds in medical advancements.

Career Highlights: Throughout his career, McIntyre has collaborated with esteemed organizations such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His time at these pharmaceutical giants has greatly influenced his research and development efforts, allowing him to bring his innovative ideas to life. His achievements in the field underscore his role as a key player in advancing medical science and addressing pressing health issues.

Collaborations: McIntyre has worked alongside noteworthy colleagues, including Nigel J. Liverton and David A. Claremon. These collaborations have undoubtedly enriched his research endeavors and contributed to the successful development of his patents, fostering an environment of innovation and scientific excellence.

Conclusion: Charles J. McIntyre's impressive track record as an inventor highlights his commitment to improving health outcomes through innovative solutions. His contributions to the development of therapeutic compounds for hepatitis C exemplify the importance of patents in transforming groundbreaking ideas into tangible benefits for society. As McIntyre continues to innovate, the impact of his work will undoubtedly resonate in the realm of pharmaceutical research and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…